StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a report published on Sunday. The firm issued a buy rating on the stock.

Mannatech Stock Performance

Shares of NASDAQ MTEX opened at $8.00 on Friday. The stock has a market cap of $15.08 million, a price-to-earnings ratio of -9.88 and a beta of 1.17. Mannatech has a 12 month low of $6.75 and a 12 month high of $10.51. The company has a 50 day simple moving average of $7.74 and a two-hundred day simple moving average of $7.54. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54.

Mannatech (NASDAQ:MTEX) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The business had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.74%.

Insider Activity at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the sale, the director now owns 54,721 shares of the company’s stock, valued at $424,087.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 41.50% of the stock is owned by company insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.